Stryker (SYK) Stock Price
Stryker Price
Stryker (SYK) Stock | ISIN US8636671013 | WKN 864952. The current Stryker stock price is 332.71 USD (2026). Revenue is 27.59 B USD. Net income is 5.84 B USD. The P/E ratio is 22. Market capitalization is 128.59 B USD. Stryker operates in the Health sector.
Over the last 19 years Stryker grew revenue by 8.7% annually, reaching 25.12 B USD. Earnings per share have grown at 8.2% per year over the last 19 years. For Stryker, the net margin of 12.9% is up versus 11.7% a few years ago. At today's price the dividend yield works out to roughly 1.02%. The payout ratio is around 48% of earnings. The dividend has grown at 15.5% per year over the past 19 years.
Stryker stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Stryker over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Stryker stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Stryker's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Stryker Price |
|---|
Stryker Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Stryker Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (B USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (B USD) |
| NET INCOME (B USD) |
| NET INCOME GROWTH (%) |
| DIVIDEND (USD)DIV. (USD) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | 2030e |
|---|---|---|---|---|---|---|---|
| 20.5 | 22.6 | 25.12 | 27.59 | 29.9 | 32.38 | 34.93 | 38.76 |
| 11.11 | 10.23 | 11.16 | 9.85 | 8.36 | 8.3 | 7.88 | 10.97 |
| 63.9 | 64.26 | 64.57 | 58.78 | 54.25 | 50.09 | 46.43 | 41.84 |
| 13.1 | 14.52 | 16.22 | 16.22 | 16.22 | 16.22 | 16.22 | 16.22 |
| 3.17 | 2.99 | 3.25 | 5.84 | 6.54 | 7.26 | 7.66 | 9.03 |
| 34.22 | -5.43 | 8.45 | 80.04 | 11.94 | 10.94 | 5.59 | 17.81 |
| 3.05 | 3.24 | 3.4 | 3.52 | 8.25 | 9.16 | - | - |
| 7.77 | 6.23 | 4.94 | 3.53 | 134.38 | 11.03 | – | – |
| 383.7 | 385.6 | 386.5 | 386.5 | 386.5 | 386.5 | 386.5 | 386.5 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Stryker generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Stryker retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Stryker's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Stryker has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Stryker's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Stryker stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Stryker Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Stryker business model & stock analysis
Stryker SWOT Analysis
Strengths
1. Strong market presence: Stryker Corp is a leading global medical technology company known for its innovative products and solutions.
2. Diverse product portfolio: The company offers a wide range of medical devices, orthopedic implants, surgical equipment, and other healthcare products, enabling it to cater to various healthcare needs.
3. Established brand reputation: Stryker Corp has built a strong brand image over the years, known for its quality, reliability, and advanced technology.
4. Strong financial performance: The company has consistently delivered positive financial results, with significant revenue growth and profitability.
Weaknesses
1. Dependence on key markets: Stryker Corp relies heavily on specific geographic regions for its revenue, making it vulnerable to fluctuations in those markets.
2. Vulnerability to regulations: The medical technology industry is subject to stringent regulations and compliance requirements, which may pose challenges for the company's operations.
3. Limited manufacturing capacity: In some product categories, Stryker Corp may face constraints in scaling up production to meet growing demand.
Opportunities
1. Growing global healthcare market: The increasing healthcare needs, particularly in emerging markets, present opportunities for Stryker Corp to expand its customer base and introduce new products.
2. Technological advancements: Stryker Corp can leverage advancements in areas such as robotics, digital health, and artificial intelligence to develop innovative and differentiated products.
3. Expansion through acquisitions: The company can explore strategic acquisitions to enhance its product offerings, enter new markets, or strengthen its existing market presence.
Threats
1. Intense competition: Stryker Corp operates in a highly competitive market, facing competition from both established medical technology companies and new entrants.
2. Economic instability: Fluctuations in global economic conditions can impact healthcare spending, thereby affecting the demand for Stryker Corp's products.
3. Product recalls or liabilities: Any product recalls or legal liabilities related to the company's products could damage its reputation and result in financial losses.
Stryker Segments
Stryker Revenue by Segment (1/5)
Max
Details
Stryker Revenue by Segment (2/5)
3 Years
5 Years
Max
Details
Stryker Revenue by Segment (3/5)
Max
Details
Stryker Revenue by Segment (4/5)
3 Years
5 Years
10 Years
Max
Details
Stryker Revenue by Segment (5/5)
3 Years
5 Years
Max
Details
Stryker Revenue by Region
3 Years
5 Years
10 Years
Max
Details
Stryker Eulerpool Fair Value
Stryker historical P/E ratio, EBIT multiple, and P/S ratio
Stryker annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Stryker shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Stryker Dividend History
30 years of dividend payments · 10 consecutive increases
Stryker dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Stryker dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Stryker Earnings Calls
Stryker Earnings Estimates
Stryker Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 4/30/2026 | 3.01USD | 6.4 BUSD | 2026 Q1 |
| 1/29/2026 | 4.44USD | 7.19 BUSD | 2025 Q4 |
| 4/29/2024 | 2.56USD | 5.17 BUSD | 2024 Q1 |
| 1/29/2024 | 3.3USD | 5.65 BUSD | 2023 Q4 |
| 7/24/2023 | 2.4USD | 4.78 BUSD | 2023 Q2 |
| 4/26/2023 | 2.16USD | 4.54 BUSD | 2023 Q1 |
| 1/25/2023 | 2.86USD | 5.03 BUSD | 2022 Q4 |
| 10/31/2022 | 2.25USD | 4.52 BUSD | 2022 Q3 |
| 7/26/2022 | 2.3USD | 4.6 BUSD | 2022 Q2 |
| 4/28/2022 | 1.97USD | 4.25 BUSD | 2022 Q1 |
EESG©
Eulerpool ESG Scorecard© for the Stryker stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Stryker shareholder structure
| % | Name |
|---|---|
8.73091% | |
5.1892% | |
4.35649% | |
4.28569% | |
3.94681% | |
2.48528% | |
2.07113% | |
1.9497% | |
1.68002% | |
1.66736% |
Stryker Executives and Management Board
Mr. Kevin Lobo
(60)Chairman of the Board, President, Chief Executive Officer · since 2011
Mr. Spencer Stiles
(49)President, Chief Operating Officer
Mr. J. Andrew Pierce
(51)Group President - MedSurg and Neurotechnology
Mr. Viju Menon
(57)Group President - Global Quality and Operations
Mr. Robert Fletcher
(54)Vice President, Chief Legal Officer
Stryker Supply Chain
Frequently asked questions about Stryker
The business model of Stryker Corp focuses on providing innovative medical technologies and solutions worldwide. As a leading medical technology company, Stryker Corp specializes in products and services across various segments, including orthopedics, medical and surgical, neurotechnology, and spine. With a strong emphasis on research and development, Stryker Corp strives to deliver advanced and effective healthcare solutions to improve patient outcomes. The company's commitment to innovation, quality, and customer satisfaction has made it a trusted name in the medical industry. Stryker Corp's business model revolves around leveraging its expertise and cutting-edge technologies to meet the evolving needs of healthcare professionals and enhance the lives of patients.
Stryker stock
Stryker Peer Group
Stryker Ticker
Stryker FIGI
All fundamentals and in-depth analysis of Stryker
Our stock analysis for Stryker Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Stryker Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.